News

Medical Dialogues2h
Cardiac safety data of Tirzepatide released: Tirzepatide offers additional cardiac benefits over Dulaglutide in SURPASS-CVOT Trial
Topline results from the SURPASS-CVOT trial reveal that once-weekly tirzepatide (Mounjaro) has a cardiovascular risk profile ...
Cryptopolitan on MSN16h
Wall Street braces for data-packed week as Fed events, PMI and 120 earnings reports collide
Wall Street has no breathing room this week as August kicks off with a flood of economic data, high-stakes Fed talk, and ...